Category: Pharmaceuticals
Biotech firm Merus N.V. has announced that the company has agreed to provide an exclusive license to Betta Pharmaceuticals Co. Ltd. for developing and commercializing Merus Biclonics® MCLA-129 in China. Under the terms of the agreement, Merus would retain all the rights outside of China …
Biotechnology firm Cybrexa Therapeutics, that was developing a new class of cancer therapeutics via its tumor targeting platform alphalex™, has recently announced that the company chose CBX-11 as the leading clinical development candidate for treating patients with various types of solid tumors. Apparently, the company …
The draft National Commission for Indian Systems of Medicine Bill, 2018, that was formed to replace the Central Council for Indian Medicine, which is current regulatory body for medicines in India, has recently been approved by the Union Cabinet. An official statement declared that the …
Perlara, the U.S. based biotech public benefit corporation that is dedicated to discovering cures for rare diseases, recently announced a partnership with Rambam Medical Center in Israel and Dr. Karl Skorecki, a leading kidney disease researcher and nephrologist, to co-develop a PerlQuest into APOL1 kidney disease. For …
Scientists have reportedly developed a new drug with the potential to prevent the breakdown of nerves and brain cells that may result in Parkinson’s, Alzheimer’s, and motor neuron diseases. As per trusted sources, the drug has been developed from supercharged vitamin A, a micronutrient that’s …
Roche Holding AG has reportedly been granted the PRIME (PRIority MEdicines) designation in Europe for its risdiplam, a small-molecule drug for spinal muscular atrophy which could be a rival to Spinraza from Biogen Inc. As of now, risdiplam is allegedly in three studies which include …
Sanofi’s Lantus to come under further revenue squeeze as Mylan now prepares to launch its own insulin glargine Mylan, the generic drug manufacturer of the United States, recently announced that infringement claims made by Sanofi about its insulin drug Lantus against Mylan have been rejected …
One of United States’ largest vertically integrated multistate cannabis operator Cresco Labs has reportedly attained approval to run a marijuana dispensary in Ohio. According to sources familiar with the development, the new facility, named CY+, situated in the village of Wintersville, will offer physician-certified patients …
HeartFlow has made it to the headlines for announcing the initiation of its PRECISE trial which is developed to compare the conventional approach of diagnosing and examining patients suffering from stable chest pain using a stress test or invasive cardiac catheterization to a new Precision …
